AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23702610
Drug: AGV implant
RxNorm normalized name: petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGV implant surgery with donor scleral patch
Trial: 21388309
Drug: Olmesartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (40 mg once daily)
Trial: 19930508
Drug: Repeated testing
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated testing (SE-T/MG-S group)
Trial: 19930508
Drug: Repeated study
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated study (MG-T/SE-S group)
Trial: 9260068
Drug: Ethanol (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.5, 1.0, and 2.0 g/kg)
Trial: 9260068
Drug: Pentobarbital (150,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentobarbital (150, 300, 600, and 750 mg/70 kg)
Trial: 2545773
Drug: Oral dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dextroamphetamine 20 mg
Trial: 81190
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (BACON combination, slightly modified)
Trial: 28452960
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg per day Pycnogenol® (P+)
Trial: 28452960
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Co)
Trial: 24306695
Drug: 1.0 mg/mL
RxNorm normalized name: P.T.E.-4, 1 mcg-0.1 mg-0.025 mg-1.0 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/mL rhBMP-2/CPM
Trial: 24306695
Drug: 2.0 mg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg/mL rhBMP-2/CPM
Trial: 17099012
Drug: Zolpidem (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (oral hypnotic agent)
Trial: 8907804
Drug: Indobufen [200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indobufen [200 mg orally twice daily (p.o. b.i.d.) for a week]
Trial: 1685875
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg lormetazepam alone
Trial: 1685875
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg lormetazepam with 200 mg cimetidine
Trial: 25402429
Drug: 2% M.
RxNorm normalized name: Methylcellulose 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% M. hamburg grape seed extract formulation
Trial: 17634482
Drug: AZD2171 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD2171 (0.5 to 60 mg, once-daily)
Trial: 17634482
Drug: AZD2171 (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD2171 (20, 30, or 45 mg, once-daily)
Trial: 17634482
Drug: AZD2171 (once-daily)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD2171 (once-daily)
Trial: 7535040
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin (6 x 10(6) KIU) (Group B)
Trial: 30472123
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg IV ibuprofen in 100 mL saline
Trial: 28225506
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL saline solution
Trial: 28283286
Drug: Prophylactic platelet
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic platelet transfusion plus supportive care (4 units of pooled platelets given daily when platelet count was 20,000 per μL or lower)
Trial: 19623149
Drug: L‐adrenaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L‐adrenaline
Trial: 11599649
Drug: 90-mg weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90-mg weekly enteric-coated fluoxetine
Trial: 11599649
Drug: 20-mg daily
RxNorm normalized name: glecaprevir
DrugBank: Glecaprevir (DB13879)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 20-mg daily fluoxetine
Trial: 2831788
Drug: Enalapril (10‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10‐20 mg) with hydrochlorothiazide plus amiloride
Trial: 2831788
Drug: Timolol (10‐20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (10‐20 mg) with hydrochlorothiazide plus amiloride
Trial: 15016559
Drug: Bimatoprost 0.03%
RxNorm normalized name: BIMATOPROST 0.03% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost 0.03% ophthalmic solution QD (n=38)
Trial: 15016559
Drug: Latanoprost 0.005%
RxNorm normalized name: LATANOPROST 0.005% SOLN,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 0.005% ophthalmic solution QD (n=38)
Trial: 15016559
Drug: Timolol gel-forming
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol gel-forming ophthalmic solution 0.5% QD (n=39)
Trial: 12516489
Drug: Diclofenac 1
RxNorm normalized name: diclofenac 18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1 mg/Kg i.m. 60 minutes before surgery and continuous infusion of 1.5 mg/Kg over 24 hours (DD)
Trial: 12516489
Drug: Diclofenac 1
RxNorm normalized name: diclofenac 18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1 mg/Kg i.m. 60 minutes before surgery and infused saline solution after extubation (DP)
Trial: 9690730
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole o.m. plus amoxycillin 1000 mg b.d. plus clarithromycin 500 mg b.d. (O20AC500)
Trial: 9690730
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole o.m. plus amoxycillin 1000 mg b.d. plus clarithromycin 1000 mg b.d. (O20AC1000)
Trial: 9690730
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole b.d. plus amoxycillin 1000 mg b.d. plus clarithromycin 500 mg b.d. (O40AC500)
Trial: 9690730
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole b.d. plus amoxycillin 1000 mg b.d. plus clarithromycin 1000 mg b.d. (O40AC1000)
Trial: 7864315
Drug: Epidural administration
RxNorm normalized name: epidural administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural administration of alfentanil (1 mg followed by 0.2 mg.h-1 infusion)
Trial: 7864315
Drug: Epidural administration
RxNorm normalized name: epidural administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural administration of alfentanil
Trial: 1081905
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with 1 chemotherapy agent
Trial: 1081905
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with 2 chemotherapy agents
Trial: 1081905
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with 3 chemotherapy agents
Trial: 1081905
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with 4 chemotherapy agents
Trial: 1081905
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with 3 drugs plus supplemental chemotherapy or irradiation (special categories)
Trial: 29423663
Drug: Placebo formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo formulations spiked with silicone oil
Trial: 29423663
Drug: Protein formulations
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein formulations stressed via freeze-thaw cycling, thermal incubation, and acid treatment
Trial: 24482301
Drug: Ustekinumab 45
RxNorm normalized name: USTEKINUMAB 45MG/0.5ML INJ 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ustekinumab 45 mg or 90 mg at week 0, week 4, q12 weeks
Trial: 22677045
Drug: Subcutaneous ixekizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous ixekizumab (5, 15, 50, or 150 mg)
Trial: 22677045
Drug: Subcutaneous ixekizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous ixekizumab
Trial: 16364049
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg intravenously infused over 10, 15, 20, or 30 minutes
Trial: 16364049
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg intravenously as an injection over 3 minutes
Trial: 9598622
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g co-amoxiclav intravenously followed by three further doses of oral co-amoxiclav (Group 1)
Trial: 9598622
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g co-amoxiclav intravenously (Group 2)
Trial: 7712689
Drug: Endurance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endurance training in combination with selected resistance exercises (n = 17)
Trial: 2472988
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of pirenzepine (PZ) intravenously every 12 hours
Trial: 2472988
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of pirenzepine (PZ) intravenously every 12 hours
Trial: 309031
Drug: Cold cardioplegic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold cardioplegic method (Group A) - 4 degrees C. asanguineous solution with 30 mEq. of potassium per liter infused into the aortic root for about 2 minutes after aortic cross-clamping and again after 45 minutes or when myocardial temperature rose above 19 degrees C.
Trial: 25842727
Drug: Intervention and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention and oral administration of Chinese medicine (Group A)
Trial: 25842727
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Chinese medicine only (Group C)
Trial: 23926681
Drug: Low-dose testosterone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose testosterone undecanoate capsules combined with tadalafil
Trial: 18447212
Drug: Electroacupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture plus Fluoxetine
Trial: 9821903
Drug: High-dose laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose laser therapy (5J/cm2)
Trial: 9821903
Drug: Low-dose laser
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose laser therapy (0.5J/cm2)
Trial: 9821903
Drug: Placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo laser therapy (0J/cm2)
Trial: 8179848
Drug: Nebivolol (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (1, 5, or 10 mg)
Trial: 8021909
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) (12.5 mg)
Trial: 8021909
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) (25 mg)
Trial: 8021909
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nebivolol and HCTZ
Trial: 31376435
Drug: Topical Thrombin
RxNorm normalized name: thrombin Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Thrombin (Human) Grifols (TTH-Grifols)
Trial: 28669689
Drug: rHuEPO (epoetin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO (epoetin β; mean dose 6000 IU per week)
Trial: 23439901
Drug: SBME mastery
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBME mastery learning for child intravenous line placement (CIV)
Trial: 21739598
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral antioxidant supplementation (900 IU of alpha‐tocopherol, 200 mg of ascorbic acid, and 600 mg of alpha‐lipoic acid)
Trial: 19545481
Drug: Group-based mindfulness
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based mindfulness training (twice-weekly sessions for 5 weeks, plus home practice)
Trial: 16481635
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus vitamin D supplementation (1000 mg of elemental calcium as calcium carbonate with 400 IU of vitamin D3 daily)
Trial: 15318466
Drug: Propofol 2
RxNorm normalized name: propofol 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2 mg kg(‐1) intravenously
Trial: 8282920
Drug: Erection enhancement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erection enhancement pill
Trial: 8282920
Drug: Erection detraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erection detraction pill
Trial: 29929437
Drug: Intervention Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention Group (IG) - participated in six group sessions with an active peer model, received exercise prescription and PA information
Trial: 24694983
Drug: Colchicine (0·5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0·5 mg twice daily for patients >70 kg or 0·5 mg once daily for patients ≤70 kg)
Trial: 22541841
Drug: Oral naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naloxone 5 mg
Trial: 22541841
Drug: Oral naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naloxone 20 mg
Trial: 22541841
Drug: Oral naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naloxone 40 mg
Trial: 22541841
Drug: Oral naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naloxone 80 mg
Trial: 22541841
Drug: Oral naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naloxone 120 mg
Trial: 22541841
Drug: Rectal naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal naloxone (dose not specified)
Trial: 19935757
Drug: Cranberry extract
RxNorm normalized name: CRANBERRY EXTRACT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry extract tablets
Trial: 16019862
Drug: Local hyperthermia
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local hyperthermia treatment (30-min sessions twice a week for 5 weeks, total of 20 sessions at 39-40 degrees C)
Trial: 16019862
Drug: Intra-plaque infiltrations
RxNorm normalized name: Plaquenil
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-plaque infiltrations using 10 mg verapamil (one infiltration once a week for 3 months)
Trial: 10807619
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate 500 microgram twice daily
Trial: 1640130
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection of midazolam
Trial: 1640130
Drug: Bolus injection
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injection followed by continuous infusion of midazolam
Trial: 6696291
Drug: Inhaled diphemanil
RxNorm normalized name: Diphemanil
DrugBank: Diphemanil (DB13720)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled diphemanil (2 mg)
Trial: 27876353
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow mononuclear cell (MNC) injections intradermally
Trial: 27876353
Drug: Placebo injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injections intradermally
Trial: 22481421
Drug: Procaine penicillin
RxNorm normalized name: procaine penicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaine penicillin (50,000 units/kg OD IM) and gentamicin (5 mg/kg OD IM)
Trial: 22481421
Drug: Ceftriaxone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (50 mg/kg OD IM)
Trial: 22481421
Drug: Oral trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trimethoprim-sulfamethoxazole (TMP-SMX) at 10 mg/kg/day divided twice daily and gentamicin IM OD
Trial: 19917596
Drug: Trauma-focused treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused treatment
Trial: 19917596
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education group treatment
Trial: 18401254
Drug: Sedatives and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedatives and opioids
Trial: 29243546
Drug: Sedatives
RxNorm normalized name: SEDATIVES/HYPONTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedatives
Trial: 10475317
Drug: Propofol plus
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol plus fentanyl (100 microg) with 1.5% lidocaine and epinephrine test dose
Trial: 10475317
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with 1.5% lidocaine and epinephrine test dose
Trial: 10475317
Drug: Saline control
RxNorm normalized name: GLYCERIN 0.53 g in 1 mL CUTANEOUS INJECTION [Glycerol-Saline Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline control group (3 mL isotonic sodium chloride solution)
Trial: 10475317
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (propofol and propofol-fentanyl) with test dose
Trial: 7815584
Drug: 15% and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% and 20% papaverine base gel applied to the scrotum, perineum, and penis
Trial: 7815584
Drug: 15% and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% and 20% papaverine base gel
Trial: 1941852
Drug: Intralesional interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional interferon alpha-2b (1.5 million units, nine injections)
Trial: 7023494
Drug: Fluproquazone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluproquazone (100 mg)
Trial: 30589790
Drug: Acetyl-L-Carnitine 3000
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-Carnitine 3000 mg/day for 2 months
Trial: 25534726
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg nemonoxacin
Trial: 25534726
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg nemonoxacin
Trial: 25534726
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg nemonoxacin
Trial: 21107298
Drug: SCE‐A vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCE‐A vaginal cream (1 g once daily for 7 days, then twice weekly for 27 days)
Trial: 21107298
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg SCE‐A oral tablets (once daily for 27 days)
Trial: 19365317
Drug: Best medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best medical therapy (proton pump inhibitors)
Trial: 17065847
Drug: Valacyclovir 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 1.0 g daily for 6 months
Trial: 14742366
Drug: i.v. parecoxib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. parecoxib 40 mg followed by oral valdecoxib 40 mg
Trial: 10467840
Drug: Serum ADA
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum ADA level > or = 53.76 U/l
Trial: 2079774
Drug: Alcohol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (mean blood alcohol level approximately 69.5 mg%; SE 6.20 mg%)
Trial: 30770519
Drug: IV golimumab
RxNorm normalized name: Golimumab
DrugBank: Golimumab (DB06674)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IV golimumab 2 mg/kg at weeks 0, 4, 12, and 20
Trial: 26433431
Drug: Daptomycin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daptomycin (4 mg/kg once)
Trial: 26433431
Drug: Vancomycin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (15 mg/kg every 12 h)
Trial: 9602597
Drug: No volatile
RxNorm normalized name: coal tar pitch volatiles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No volatile agent
Trial: 19175400
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 10 mg/kg twice daily (b.i.d.)
Trial: 19175400
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 20 mg/kg twice daily (b.i.d.)